Flex Pharma Co-Founder And Harvard Medical School Professor Bruce Bean To Speak About Chemical Neuro Stimulation At Neuro Advance Boston
BOSTON--(BUSINESS WIRE)--Click to Tweet this News
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions, announced that Chief Medical Officer, Dr. Tom Wessel, will lead a panel of thought leaders including National Academy of Sciences member Dr. Bruce Bean, Professor of Neurobiology at Harvard Medical School, regarding chemical neuro stimulation as a new therapeutic modality to treat and prevent muscle cramps and spasms, at the Neuro Advance Boston Conference on October 14, 2015, held at Harvard Medical School.
Help employers find you! Check out all the jobs and post your resume.
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions, announced that Chief Medical Officer, Dr. Tom Wessel, will lead a panel of thought leaders including National Academy of Sciences member Dr. Bruce Bean, Professor of Neurobiology at Harvard Medical School, regarding chemical neuro stimulation as a new therapeutic modality to treat and prevent muscle cramps and spasms, at the Neuro Advance Boston Conference on October 14, 2015, held at Harvard Medical School.
Help employers find you! Check out all the jobs and post your resume.